Weight can return if treatment stops, particularly if lifestyle changes are not maintained
And pills are generally cheaper for pharmaceutical manufacturers to produce than injectable medications, which could potentially translate to lower costs for consumers
Hypoglycemia risk: Patients taking GLP-1 agonists with insulin or sulfonylureas need close glucose monitoring, as dose adjustments of these medications may be necessary
All of these factors can contribute to poor production of glutathione (or of the enzymes that help glutathione to do its work), and many also deplete the GSH that the cells produce (by converting it into GSSG)
By contrast, MACE risk was significantly lower among those who continued GLP-1RA use for 2 and 2.5 years, and lowest among those who maintained treatment for three years
Injections are very effective at raising blood levels of vitamin B12 and preventing or reversing a B12 deficiency